1990
DOI: 10.1016/0014-5793(90)80102-o
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of epidermal growth factor‐induced DNA synthesis by tyrosine kinase inhibitors

Abstract: We prepared methyl 2,.5-dihydroxycinnamate as a stable analogue of erbstatin, a tyrosine kinase inhibitor. This analogue was about 4 times more stable than erbstatin in calf serum. It inhibited epidermal growth factor receptor-associated tyrosine kinase in vitro with an XC, of 0.15 pg/ml. It also inhibited in situ autophosphorylatio~ of epidermal growth factor receptor in A43I cells. Methyl 2,5-dihy~oxycinn~ate was shown to delay the S-phase induction by epidermal growth factor in quiescent normal rat kidney c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
57
0

Year Published

1993
1993
2006
2006

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 126 publications
(61 citation statements)
references
References 8 publications
4
57
0
Order By: Relevance
“…The present results are the first to show that the CPAinduced vasorelaxation, accompanied by increased cyclic GMP formation, was inhibited by methyl 2,5-dihydroxycinnamate, which has been reported to be a tyrosine kinase inhibitor (10). In rat thoracic aorta, it has been previously assumed by us (2) that CPA may act on the ER in endothelial cells to deplete Ca 2+ by inhibition of the Ca 2+-pumping ATPase, which then triggers the influx of extracellular Ca 21 in a similar way to that proposed in the capacitative Ca 2+ entry model for parotid acinar cells (3) and cultured endothelial cells (5).…”
supporting
confidence: 58%
“…The present results are the first to show that the CPAinduced vasorelaxation, accompanied by increased cyclic GMP formation, was inhibited by methyl 2,5-dihydroxycinnamate, which has been reported to be a tyrosine kinase inhibitor (10). In rat thoracic aorta, it has been previously assumed by us (2) that CPA may act on the ER in endothelial cells to deplete Ca 2+ by inhibition of the Ca 2+-pumping ATPase, which then triggers the influx of extracellular Ca 21 in a similar way to that proposed in the capacitative Ca 2+ entry model for parotid acinar cells (3) and cultured endothelial cells (5).…”
supporting
confidence: 58%
“…The inactive genistein analogue, daidzein (100 M), did not inhibit (not shown). Erbstatin analogue, a tyrosine kinase inhibitor not chemically related to genistein (18), also completely suppressed receptor-activation of TRPC3 (Fig. 1A).…”
Section: Resultsmentioning
confidence: 92%
“…Daidzein did not affect E-selectin expression induced by IL-la or TNFa at concentrations up to 100 pM (30 pg ml-1); however, 100 pM daidzein partially inhibited PMA-induced expression (24 + 6% inhibition, P<0.001). An additional tyrosine kinase inhibitor, methyl-2,5-dihydroxy-cinnamate (MDHC), which is a stable analogue of erbstatin (Umezawa et al, 1990) failed to inhibit IL-la-, TNFa-or PMA-induced E-selectin expression at concentrations up to 20 pM (data not shown). At concentrations exceeding 20 pM MDHC was cytotoxic.…”
Section: Discussionmentioning
confidence: 99%